...
首页> 外文期刊>Hybridoma >Several Commercially Available Anti-CCR5 Monoclonal Antibodies Lack Specificity and Should Be Used with Caution
【24h】

Several Commercially Available Anti-CCR5 Monoclonal Antibodies Lack Specificity and Should Be Used with Caution

机译:几种市售的抗CCR5单克隆抗体缺乏特异性,应谨慎使用

获取原文
获取原文并翻译 | 示例
           

摘要

CCR5 (CD195) is a receptor for the chemokines RANTES, MlP-1alhpa, and MIP-1beta and is used by HIV-1 as a co-receptor for entry into macrophages and CD4 + T cells. CCR5 exists in multiple conformations in the membrane and is present at low levels on human macrophages, making it difficult to detect. Nine commercially available anti-CCR5 monoclonal antibodies were evaluated for their specificity and their recognition of CCR5 expressed by macrophages. Unexpectedly, we found that three of the nine clones tested displayed substantial background binding to CCR5 negative cells, suggesting that these antibodies may give unreliable results. We recommend the use of clones CTC8, 45531 (PE conjugated), and 45523 and advise that data obtained using CTC5, 45531 (unconjugated), and 45549 anti-CCR5 antibody clones should be interpreted with care.
机译:CCR5(CD195)是趋化因子RANTES,MlP-1alhpa和MIP-1beta的受体,并被HIV-1用作进入巨噬细胞和CD4 + T细胞的共受体。 CCR5以多种构象存在于膜中,在人类巨噬细胞上的含量较低,难以检测。评价了九种市售抗CCR5单克隆抗体的特异性和它们对巨噬细胞表达的CCR5的识别。出乎意料的是,我们发现测试的9个克隆中有3个显示出与CCR5阴性细胞的实质性背景结合,表明这些抗体可能给出不可靠的结果。我们建议使用克隆CTC8、45531(PE偶联)和45523,并建议对使用CTC5、45531(非偶联)和45549抗CCR5抗体克隆获得的数据进行仔细解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号